Research roundup: diagnostic and prognostic cancer markers
Interested in seeing more of our cancer research antibodies in action? The following three studies have successfully utilized different Atlas Antibodies products to suggest or identify new biomarkers for different cancers.
Research roundup: see our neuroscience products in action
Our antibodies are used in cutting-edge neuroscience research around the world. Let's take a look at three recent studies showing our antibodies in action. Today we show some evidence about proteins in post-mortem Alzheimer's disease brain, novel autoantibodies from the serum of patients with melanoma-associated retinopathy, and proteins causing neurodevelopmental disorder.
Interview with a scientist: proteomics, biomarkers and ALS.
No effective therapies are currently available for Amyotrophic Lateral Sclerosis- ALS due to the lack of biomarkers for early diagnosis and monitoring disease progression. Meet here, Dr. Valentina Bonetto, and read about her research efforts based on proteomic assays to find validated biomarkers and innovative therapeutic strategies to treat ALS.
Research roundup: neuroscience antibodies and protein standards
Our highly-validated antibodies and QPrEST protein standards are used in cutting-edge neuroscience research. Read a roundup of some newly published studies to see our neuroscience antibodies and targeted proteomics in action!
Research Roundup: prognostic biomarkers in cancer
Many of our cancer antibodies are used in cutting-edge research to identify new prognostic markers in different cancers. Let's take a look at three recent studies.
Now I see you: the imaging toolbox that improves the detection of primary ciliary dyskinesia
Ciliopathies are inherited human disorders that affect primary cilia genes. The authors of this study took part in our Explorer Program. Read on to discover what they found.
Liquid biopsy: what is written in the blood?
Liquid biopsy is a non-invasive sampling approach also used to predict the progression and growth dynamics of cancer and provide guidance for therapy monitoring. This blog covers various features and issues associated with liquid biopsy as exemplified by tumor markers.
Microglia: the brain’s immune barrier at the interface of good and bad
In this blog post, we share an overview of the existing knowledge regarding the neuro-modulatory function of microglia.
Candidate diagnostic biomarkers for lung cancer
In this blog, we discuss the rapidly evolving field of targeted drug therapy in lung cancer.
Keep reading to learn more!
Primary antibodies and clinical research: 3 case studies
Research antibodies have wide applicability and transferability and are enormously useful over a wide range of domains. Read more to discover how antibodies help progressing science.